Login / Signup

Computational drug design of novel COVID-19 inhibitor.

David Ebuka ArthurBenjamin Osebi ElegbeAugustina Oyibo ArohMahmoud Soliman
Published in: Bulletin of the National Research Centre (2022)
The online version contains supplementary material available at 10.1186/s42269-022-00892-z.
Keyphrases
  • coronavirus disease
  • sars cov
  • social media
  • psychometric properties
  • health information
  • respiratory syndrome coronavirus
  • adverse drug
  • drug induced
  • healthcare